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Summary.-Peers and Linsell (1973) demonstrated a significant association between
the incidence of primary liver cancer and ingested aflatoxin in a study in the Muranga
district of Kenya. A study of hepatitis B antigen in the same district showed no
significant differences between the low altitude area, with a relatively high incidence
of primary liver cancer, and the high altitude area with a lower incidence of the
tumour. Current evidence is more in favour of aflatoxin playing an important role
in the aetiology of primary liver cancer but hepatitis B antigen may play an ancillary
role.
EPIDEMIOLOGICAL and experimental
evidence is accumulating to implicate
aflatoxins and the virus oftype B hepatitis
in the aetiology of primary liver cancer
(PLC). The carcinogenic potential of
aflatoxins is well established in animals
(Goldblatt, 1969). Approximate rela-
tionships between aflatoxin contamination
of market food samples and the incidence
of PLC have been reported from Uganda
(Alpert et al., 1971), Swaziland (Keen and
Martin, 1971.) and Thailand (Shank et al.,
1972). Studies correlating the incidence
of PLC with the amount of aflatoxin
actually consumed are of greater signifi-
cance and Peers and Linsell (1973) carried
out one such study in the Muranga district
of Kenya. This district slopes from
2500 ft to 12,000 ft above sea level and
Peers and Linsell were able to compare
results in different areas delineated by
altitude. Using contour lines at 5250 ft
and 6500 ft the study was divided into
sub-areas of low, middle and high alti-
tudes. The results revealed a significant
correlation in the incidence of PLC and
dietary aflatoxin in the three altitude
areas. In the low altitude area PLC
incidence was greater and aflatoxin levels
in the food samples were higher.
Hepatitis B antigen (HBsAg), the
marker of hepatitis B virus, is found more
frequently in the serum of patients with
PLC than in control sera, particularly
in countries with high HBsAg carrier
rates (Prince, 1971), but this association
may relate to coexisting cirrhosis. The
absence, until recently, of suitable ani-
mals to use as models of infection with
viral hepatitis has prevented the possible
experimental proofofoncogenic properties
ofhepatitis B virus and thus increased our
dependence on epidemiological studies for
assessing the role which this virus plays in
the aetiology of PLC. Transmission of
the virus of hepatitis B is no longer con-
sidered to be solely by direct parenteral
routes. There is some evidence of trans-
mission by other routes, including insect
vectors. Faecal-oral transmission and
transmission by insect vectors may vary
with temperature and humidity, and
altitude could be a factor influencing the
frequency of transmission of hepatitis B
antigen. If hepatitis B virus played the
dominant role in the aetiology of PLC,
transmission and infection would probably
be more common in the low altitude area
of Peers and Linsell, where the incidence
of PLC was greater. This study was
designed to measure the prevalence of
hepatitis B antigenaemia, as a guide to the
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prevalence of hepatitis B virus, in these
areas.
MATERIALS AND METHODS
Field sampling.-Using summated popu-
lation data, 3 sub-locations (cluster centres)
were selected from both high and low
altitude areas as detailed by Peers and
Linsell (1973). WAithin each sub-location
population sampling was carried out on a
household basis and 2 household clusters
numbering approximately 200 people each
were sampled from each sub-location. The
first household of each cluster was selected
and the following household was selected as
that nearest, in a straight line, to the house-
hold just completed. Members of a house-
hold were defined as any person eating from
the household kitchen for 3 months or more.
Blood sampling.-Blood from a finger
prick was collected in duplicate in heparinized
capillary tubes which were then sealed at one
end (using Cristaseal) and placed open end
uppermost. Samples were stored at 4°C
until transferred to Nairobi where they were
kept at - 25°C. Thick and thin blood films
were made and, after air drying, w%Aere trans-
ferred to Nairobi. Giemsa staining (Baker,
Silverton and Luckock, 1966) and examina-
tion were carried out at the Division of
Insect Borne Diseases, Nairobi.
Hepatitis B antigen testing.-Initial tests
for HBsAg were carried out in Nairobi by
counterimmunoelectrophoresis (CIEP) using
Pfizer antiserum prepared in goats. Details
of the technique have been published
previously (Parker, Mururi and Preston,
1971). The duplicate samples were sent to
the Middlesex Hospital, London and radio-
immunoassay (RIA) testing for HBsAg was
carried out as follows:
An approximate 1 in 25 dilution of the
blood specimen was made in TRIS buffered
saline with 0.1% sodium azide, giving
approximately a 1 in 50 serum dilution. The
methods employed for detection, quantita-
tion and subtyping by RIA have been des-
cribed in outline previously (Heatheote,
Cameron and Dane, 1974). Polystyrene
tubes were coated with antibody from a
rabbit immunized with purified HBsAg. In
the standard test for screening, 0.1 ml
volumes of the diluted specimens were
placed in the previously coated tubes and
left overnight. After washing, 0 1 ml of
125lodine labelled rabbit anti-HBsAg w%as
added to each tube. After a further 12 h the
tubes were washed and counted for radio-
activity. Dilutions ofan HBsAg sub-type ad
positive control serum wNere included in each
batch of tests. For assay of HBsAg, dilu-
tions of positive specimens wNere made in
normal human serum and the results were
expressed in arbitrary units based on the
HBsAg control serum. In the present study,
because of the initial dilutions of the sample,
the lower limit of detection was 50 units.
The HBsAg detection sensitivity achieved in
the RIA screening at the 1 in 50 dilution of
serum tested was approximately eight-fold
greater than that which w%rould have been
obtained by CIEP screening of undiluted
serum.
RESULTS
As expected, RIA proved to be coI-
siderably more sensitive than CIEP and
only the former results are reported.
One thousand eight hundred and thirty-
three samples from the study population
of 2644 (69.3%) were tested. Five hun-
dred and twenty-seven people were not
available for sampling and the duplicate
sample from a further 284 people was not
satisfactory. HBsAg was detected in 59
samples (3.2%): 21 positive samples
(2.7%) were from the high altitude area
and 38 (3.6%) from the low altitude area.
This difference is statistically not signifi-
cant (X2 1.18) (Table I). The pre-
valence ofantigenaemia bore no consistent
relationship to age but was greater in
males than females. Family clustering
was evident. Twenty-four positive sam-
ples were from persons with at least one
close blood relation who was also positive.
There were 6 families with 2 children
positive and in one family all 6 children
tested were positive (unfortunately neither
parent ofthis family was tested).
Two HBsAg positive parents each had
one child who was positive and there was
a grandparent with a positive grandchild.
Ofthe 59 HBsAg positive samples 57 were
sub-type ad and only 2 were sub-type ay.
The 2 subjects who were HBsAg positive
sub-type ay came from the same house-
hold. Table II shows the mean titre ofHEPATITIS BS ANTIGEN AND LIVER CANCER
TABLE I.-HBsAg Carriers in High and Low Altitude Areas of Muranga District
Age (yr) 0-9 10-19
High Altitude
(6500-12000 ft)
No. tested
No. positive
% positive
No. tested
No. positive
% positive
No. tested
No. positive
% positive
No. tested
No. positive
% positive
No. tested
No. positive
% positive
No. tested
No. positive
% positive
172
2
1 2
158
3
1.9
330
5
1.5
84
6
7-1
96
1
1
180
7
3 9
Low Altitude
(2500-5250 ft)
230
8
3-5
220
7
3-2
450
15
3.3
131
7
5.3
133
B
3-8
264
12
4.5
> 19 Unknown Total
92
4
4.3
174
5
2-9
266
9
3.4
101
4
4
232
7
3
333
11
3.3
1
0
0
1
0
0
2
0
0
6
0
0
2
0
0
8
0
0
349
12
3.4
429
9
2-1
778
21
2 7
468
19
4 1
587
19
3-2
1055
38
3-6
TABLE II.-Titres of HBsAg Found in Carriers in the High and Low Altitude Areas of
Muranga, Related to Age and Sex
Age (yr)
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
No. positive
Mean units HBsAg*
0-19 Mean age > 19
High altitude
(6500-12000 ft)
8 12 4
186875 52000
4 7.5 5
282500 29830
12 10 9
218750 39683
Low altitude
(2500-5250 ft)
15 9
180376
12 8
153127
27 8-5
168226
39 9
183799
3
14600
8
19125
11
20545
20
29157
Mean age Total Mean age
34
37
35-5
42
40
41
38-5
* Titres of HBsAg found by radioinmmunoassay are expressed in arbitrary units.
the antigen in the two study areas.
There was no quantitative difference
between the high and low altitude areas
or between males and females but titres
were higher in the younger age groups
(Table II).
Malaria parasites were not found in
any of the samples.
12
141917
9
142128
21
142007
18
154369
20
99526
38
125504
59
131377
19
20-5
21
14 5
20 8
18
19
DISCUSSION
This study has failed to demonstrate
any significant difference in the preval-
ence of HIBsAg in two geographically
different areas where the incidence of
PLC is known to differ. While not dis-
proving a possible role of HBsAg in the
aetiology of PLC, no evidence has been
Sex
Male
Female
Total (both sexes)
Male
Female
Total (both sexes)
Sex
Male
Female
Total
Male
Female
Total
Total (both
areas)
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produced to support it. The time inter-
val between the initial action of a carcino-
gen and the clinical manifestation of the
cancer is variable and may be a number
of years in PLC. A negative comparison
of current incidence of the tumour with
current prevalence of a possible causal
agent is obviously of limited significance,
particularly when the prevalence of the
agent under study might fluctuate. Pro-
longed longitudinal studies would be
necessary to demonstrate variation in
prevalence of antigenaemia and any rela-
tion to subsequent PLC.
The RIA test we used was highly
sensitive. However, because ofthe initial
1 in 25 dilution of the lysed capillary
blood, some weak HBsAg positive samples
were almost certainly missed which would
have been detected if undiluted serum
samples had been screened. This is
unlikely to have influenced the comparison
of HBsAg carrier rates in the two com-
munities.
In conclusion, this study has failed to
demonstrate any correlation between the
prevalence of HBsAg and the incidence of
PLC in 2 distinct areas where a previous
study has shown a significant correlation
of PLC incidence with dietary aflatoxins.
Present evidence favours aflatoxin as a
possible major cause of PLC in Kenya
though, because of the high incidence of
HBsAg in the blood of cases of PLC,
hepatitis B virus may well be a co-factor
in its aetiology.
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